Jill U. Adams is a freelance science journalist based in Albany, New York. She covers health, mental health and biomedical research for such publications as The Transmitter, The Washington Post, Scientific American, Undark and The Scientist. She has a Ph.D. in pharmacology from Emory University in Atlanta, Georgia.
Jill Adams
Contributing writer
From this contributor
Role of GABA-A receptors in dup15q syndrome, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 22 June.
Role of GABA-A receptors in dup15q syndrome, and more
By
Jill Adams
23 June 2026 | 2 min read
Leucovorin saga, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 15 June.
Key role of interferon 1 in maternal immune activation, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 1 June.
Key role of interferon 1 in maternal immune activation, and more
By
Jill Adams
9 June 2026 | 2 min read
Autism-linked genes expressed in thalamus make an impact, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 1 June.
Autism-linked genes expressed in thalamus make an impact, and more
By
Jill Adams
2 June 2026 | 2 min read
SHANK3-variant effects in primates, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 25 May.
Explore more from The Transmitter
From friend to foe: How the brain updates feelings toward others
A specific hippocampus-to-amygdala pathway reassigns emotional valence to a known individual, whereas the hippocampus’s own representation of that individual’s identity remains stable.
From friend to foe: How the brain updates feelings toward others
A specific hippocampus-to-amygdala pathway reassigns emotional valence to a known individual, whereas the hippocampus’s own representation of that individual’s identity remains stable.
By
Natalia Mesa
9 July 2026 | 5 min read
Mass-produced science is coming. What happens to scientists?
Artificial intelligence may soon enable researchers to generate high-quality science at a previously unimaginable speed. For science consumers—the public, medical patients, technology users—the likely effects will be positive. For scientists, the effects will be as disruptive as industrial mass production was for artisan manufacturers.
Mass-produced science is coming. What happens to scientists?
Artificial intelligence may soon enable researchers to generate high-quality science at a previously unimaginable speed. For science consumers—the public, medical patients, technology users—the likely effects will be positive. For scientists, the effects will be as disruptive as industrial mass production was for artisan manufacturers.
By
Kenneth Harris
9 July 2026 | 9 min read
Neuropathologist not guilty of research misconduct, says university probe
The investigation determined that seven papers by corresponding author Adriano Aguzzi have “scientifically significant” errors, which Aguzzi attributes to his former students.
Neuropathologist not guilty of research misconduct, says university probe
The investigation determined that seven papers by corresponding author Adriano Aguzzi have “scientifically significant” errors, which Aguzzi attributes to his former students.
By
Dalmeet Singh Chawla
8 July 2026 | 5 min read